1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Turkey Pharmaceuticals and Healthcare Report Q4 2016

Turkey Pharmaceuticals and Healthcare Report Q4 2016

  • November 2016
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates


BMI View:

Turley will remain one of the largest markets in Central and Eastern Europe for both healthcare expenditure and pharmaceutical sales, boosted by a growing and ageing population with a high prevalence of non-communicable diseases. A poor regulatory environment, intellectual property protection issues and continued geopolitical risks with its neighbours will weigh down on growth potential.

Headline Expenditure Projections

- Pharmaceuticals: TRY20.81bn (USD7.64bn) in 2015 to TRY22.98bn (USD7.76bn) in 2016; +10.5% in local currency and 1.6% US dollar terms. Forecast unchanged from previous quarter.

- Healthcare: TRY106.56bn (USD39.13bn) in 2015 to TRY119.52bn (USD40.38bn) in 2016; 12.2% in local currency and 3.2% US dollar terms. Forecast unchanged from previous quarter.

Table Of Contents

Turkey Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Turkey 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 26
OTC Medicine Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2014-2020) 31
Industry Risk/Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q4 2016 32
Turkey Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 41
Pricing Regime 44
Reimbursement Regime 45
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Turkey 2010-2015) 50
Table: Healthcare Personnel (Turkey 2010-2015) 50
Table: Healthcare Activity (Turkey 2010-2015) 51
Research and Development 51
Clinical Trials 52
Epidemiology 53
Competitive Landscape 56
Pharmaceutical Sector 56
Research-Based Industry 57
Generic Drugmakers 58
Table: Multinational Market Activity 60
Pharmaceutical Distribution 61
Pharmaceutical Retail 62
Company Profile 63
Abdi ?brahim 63
EastPharma (Deva) 67
Eczaciba?i Healthcare 70
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals 73
Sanovel Pharmaceuticals 76
Demographic Forecast 79
Table: Population Headline Indicators (Turkey 1990-2025) 80
Table: Key Population Ratios (Turkey 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Turkey 1990-2025) 81
Table: Population By Age Group (Turkey 1990-2025) 81
Table: Population By Age Group % (Turkey 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.